Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 2 40-2, 1996, Pages

  Suzuki, Hideyuke ^b   Gao, Xiao Pei ^b   Olopade, Christopher O ^b   Rubinstein, Israel ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

arterioles; intravital microscopy; microcirculation; proteinase inhibitors; proteinases

Indexed keywords

BESTATIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEUPEPTIN; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE INHIBITOR; PHOSPHORAMIDON; THIORPHAN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTICLE; ENZYME ACTIVITY; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; RESISTANCE BLOOD VESSEL; SYRIAN HAMSTER; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0029846917     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.2.r393     Document Type: Article

References (35)

1. Brizzolara, A. L., and G. Burnstock. Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit. Br. J. Pharmacol. 103: 1206-1212, 1991.
2. Davis, M. J., W. L. Joyner, and J. P. Gilmore. Microvascular pressure distribution and responses of pulmonary allografts and cheek pouch arterioles in the hamster to oxygen. Circ. Res. 49: 125-132, 1981.
3. Duggan, K. A., D. M. Jones, R. E. Davis, and G. J. MacDonald. Effect of neutral endopeptidase on plasma and tissue concentrations of vaso-active intestinal peptide. Clin. Exp. Pharmacol. Physiol. 21: 307-309, 1994.
4. Erdös, E. G., and R. A. Skidgel. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J. 3: 145-151, 1989.
5. Frase, L. L., F. A. Gaffney, L. D. Lane, J. C. Buckey, S. I. Said, C. G. Blomqvist, and G. J. Krejs. Cardiovascular effects of vasoactive intestinal peptide in healthy subjects. Am. J. Cardiol. 60: 1356-1361, 1987.
6. Gao, X.-P., P. Anding, R. A. Robbins, S. I. Rennard, and I. Rubinstein. Peptidases modulate bradykinin-induced arteriolar dilatation in the hamster cheek pouch. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H93-H98, 1994.
7. Gao, X.-P., Y. Noda, I. Rubinstein, and S. Paul. Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure. Life Sci. 54: PL247-PL252, 1994.
8. Gao, X.-P., and I. Rubinstein. Neutral endopeptidase modulates substance P-induced vasodilation in vivo. J. Appl. Physiol. 78: 562-568, 1995.
9. Gao, X.-P., and I. Rubinstein. The stable VIP analogue, Ro 24-9981, potentiates bradykinin-induced increases in clearance of macromolecules. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1648-H1655, 1995.
10. G-monomethyl arginine in endothelium-denuded vessels. Br. J. Pharmacol. 102: 567-572, 1991.
11. Goetzl, E. J., S. P. Sreedharan, C. W. Turck, R. Bridenbaugh, and B. Malfroy. Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.3.24.11). Biochem. Biophys. Res. Commun. 158: 850-854, 1989.
12. Gulbenkian, S., O. S. Opgaard, R. Ekman, N. C. Andrade, J. Wharton, J. M. Polak, J. Queiroz e Melo, and L. Edvinsson. Peptidergic innervation of human epicardial coronary arteries. Circ. Res. 73: 579-588, 1993.
13. Holzer, P., and P. H. Guth. Neuropeptide control of rat gastric mucosal blood flow. Increase by calcitonin gene-related peptide and vasoactive intestinal polypeptide, but not substance P and neurokinin A. Circ. Res. 68: 100-105, 1991.
14. Hulsmann, A. R., R. C. Jongejan, H. R. Raatgeep, T. Stijnen, I. L. Bonta, K. F. Kerrebijn, and J. C. de Jongste. Epithelium removal and peptidase inhibition enhance relaxation of human airways to vasoactive intestinal peptide. Am. Rev. Respir. Dis. 147: 1483-1486, 1993.
15. Ignarro, L. J., R. E. Byrns, G. M. Buga, and K. S. Wood. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and vasoactive intestinal peptide. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H1074-H1082, 1987.
16. Itoh, H., K. P. Lederis, and O. P. Rorstad. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide. Eur. J. Pharmacol. 181: 199-205, 1990.
17. Kaji, A., T. Maeda, and S. Watanabe. Parasympathetic innervation of cutaneous blood vessels examined by retrograde tracing in the rat lower lip. J. Auton. Nerv. Syst. 32: 153-158, 1991.
18. Kobayashi, R., Y. Chen, T. D. Lee, M. T. Davis, O. Ito, and J. H. Walsh. Degradation of vasoactive intestinal polypeptide by rabbit gastric smooth muscle membranes. Peptides 15: 323-332, 1994.
19. Lilly, C. M., L. Kobzik, A. E. Hall, and J. M. Drazen. Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs. J. Clin. Invest. 93: 2667-2674, 1994.
20. Lilly, C. M., M. A. Martins, and J. M. Drazen. Peptidase modulation of vasoactive intestinal peptide pulmonary relaxation in tracheal superfused guinea pig lungs. J. Clin. Invest. 91: 235-243, 1993.
21. Liu, L.-W., M. Trotz, E. G. Erdös, and S. I. Said. Vasoactive intestinal peptide (VIP) and helodermin: degradation by airway enzymes (Abstract). Am. Rev. Respir. Dis. 143: A618, 1991.
22. Mayhan, W. G., and W. L. Joyner. The effect of altering the external calcium concentration and a calcium channel blocker, verapamil, on microvascular leaky sites and dextran clearance in the hamster cheek pouch. Microvasc. Res. 28: 159-179, 1984.
23. Mayhan, W. G., and I. Rubinstein. Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamsters: reversal by L-arginine. Biochem. Biophys. Res. Commun. 184: 1372-1377, 1992.
24. Miao, F. J.-P., and T. J.-F. Lee. VIP-ergic and cholinergic innervations in internal carotid arteries of the cat and rat. J. Cardiovasc. Pharmacol. 18: 369-378, 1991.
25. Raud, J. Intravital microscopic studies on acute mast cell-dependent inflammation. Acta Physiol. Scand. 578, Suppl. 1-58, 1989.
26. Rivers, R. J., A. L. Loeb, N. J. Izzo, M. J. Peach, and B. R. Duling. Microcirculatory responses to exogenous endothelial cell-derived relaxing factor. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H606-H609, 1990.
27. Rubinstein, I., M. Houmsse, R. G. Davis, and J. K. Vishwanatha. Tissue angiotensin I-converting enzyme activity in spontaneously hypertensive hamsters. Biochem. Biophys. Res. Commun. 183: 1117-1123, 1992.
28. Rubinstein, I., and W. G. Mayhan. L-Arginine dilates cheek pouch arterioles in hamsters with hereditary cardiomyopathy but not in controls. J. Lab. Clin. Med. 125: 313-318, 1995.
29. Rubinstein, I., T. Yong, S. I. Rennard, and W. G. Mayhan. Cigarette smoke extract attenuates endothelium-dependent arteriolar dilatation in vivo. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1913-H1918, 1991.
30. Said, S. I., and V. Mutt. Polypeptide with broad biological activity: isolation from small intestine. Science Wash. DC 169: 1217-1218, 1970.
31. Smits, G. J., and R. A. Lefebvere. Influence of thiorphan and phosphoramidon on the relaxant effect of vasoactive intestinal polypeptide and non-adrenergic non-cholinergic neurogenic stimulation in the rat gastric fundus. Eur. J. Pharmacol. 200: 361-364, 1991.
32. Suzuki, H., Y. Noda, S. Paul, X.-P. Gao, and I. Rubinstein. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. Life Sci. 57: 1451-1457, 1995.
33. Tam, E. K., G. M. Franconi, J. A. Nadel, and G. H. Caughey. Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi. Am. J. Respir. Cell Mol. Biol. 2: 449-452, 1990.
34. Walls, A. F., S. D. Brain, A. Desai, P. J. Jose, E. Hawkings, M. K. Church, and T. J. Williams. Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem. Pharmacol. 43: 1243-1248, 1992.
35. Woie, L., K. Dickstein, and B. Kaada. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes. Gen. Pharmacol. 18: 577-587, 1987.